The signaling molecule endothelin-1 (ET-1) expressed by reactive astrocytes in MS and murine demyelinated lesions is a negative regulator of OPC differentiation and remyelination acting by promoting Notch activation in OPCs during remyelination (Hammond et al., 2014). Here, EDN1 is linked to myeloid sarcoma.